LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.27 | 770.25 | 6470 | 7058 | 0.9166 | 0.9462 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.27 | 770.25 | 6657 | 7058 | 0.9431 | 0.9637 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.27 | 770.25 | 6615 | 7058 | 0.9371 | 0.9598 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 54.49 | 770.25 | 6687 | 7555 | 0.8851 | 0.9272 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 54.49 | 770.25 | 6896 | 7555 | 0.9127 | 0.9453 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 54.49 | 770.25 | 7183 | 7555 | 0.9507 | 0.9695 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 54.49 | 770.25 | 7227 | 7555 | 0.9565 | 0.9732 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 56.71 | 770.25 | 7098 | 8001 | 0.8871 | 0.9303 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 56.71 | 770.25 | 7350 | 8001 | 0.9186 | 0.9503 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 56.71 | 770.25 | 7726 | 8001 | 0.9656 | 0.9794 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 56.71 | 770.25 | 7605 | 8001 | 0.9504 | 0.9701 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.94 | 770.25 | 7497 | 8444 | 0.8878 | 0.9323 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.94 | 770.25 | 7773 | 8444 | 0.9205 | 0.9526 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.94 | 770.25 | 8078 | 8444 | 0.9566 | 0.9745 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.94 | 770.25 | 8103 | 8444 | 0.9596 | 0.9763 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.16 | 770.25 | 7880 | 8892 | 0.8862 | 0.9327 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.16 | 770.25 | 8142 | 8892 | 0.9157 | 0.9507 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.16 | 770.25 | 8509 | 8892 | 0.9569 | 0.9752 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.16 | 770.25 | 8605 | 8892 | 0.9677 | 0.9815 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.39 | 770.25 | 8151 | 9326 | 0.8740 | 0.9265 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.39 | 770.25 | 8522 | 9326 | 0.9138 | 0.9505 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.39 | 770.25 | 8938 | 9326 | 0.9584 | 0.9765 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.39 | 770.25 | 9131 | 9326 | 0.9791 | 0.9883 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.61 | 770.25 | 8447 | 9736 | 0.8676 | 0.9239 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.61 | 770.25 | 8769 | 9736 | 0.9007 | 0.9437 | MN20160304_L02 | D05 |